{
  "id": 12356986,
  "title": "Invivoscribe® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack® Flex Suite",
  "url": "https://urgent.news/2026/10/06/invivoscribe-advances-molecular-clonality-testing-portfolio-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T10:18:31.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/invivoscribe-advances-molecular-clonality-testing-portfolio-with-comprehensive-lymphotrack-flex-suite"
  },
  "original_language": "en",
  "account": null,
  "summary": "New ultra-high sensitivity tests enable objective, automation-ready, high-throughput clonality and MRD workflow. SAN DIEGO — Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing (NGS) solution to identify and track immunoglobulin and T-cell…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}